De Sanctis, V. et al. 2022. The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients. Acta Biomedica Atenei Parmensis. 93, 2 (May 2022), e2022162. DOI:https://doi.org/10.23750/abm.v93i2.12056.